SB 837 — Maryland
Maryland Medical Assistance Program and Health Insurance - Coverage and Utilization Review - Drugs Reviewed by the Prescription Drug Affordability Board
Prohibiting a managed care organization and certain insurers, nonprofit health service plans, and health maintenance organizations from requiring a prior authorization or step therapy or fail-first protocol under certain circumstances for prescription drugs that have been reviewed by the Prescription Drug Affordability Board; etc.
Latest action: Hearing 3/04 at 1:00 p.m. · Feb 12, 2026
Synopsis written by the legislature's own staff, as published on the official bill page. Status label is derived from the recorded actions. The full text below is the record.
Committees: Finance (Senate)
Cross-filed with HB 1440 — the companion bill in the other chamber, as the legislature links it. Each bill keeps its own votes and status; they are never combined here.
Updated Mar 17, 2026
Timeline
First Reading Finance
Feb 6, 2026 · Senate
Hearing 3/04 at 1:00 p.m.
Feb 12, 2026 · Senate
Sponsored by Justin Ready, Clarence Lam
No recorded floor votes yet.
How we know this
Every line above comes from the Maryland General Assembly record via Open States. The motion text is shown as recorded, so a procedural vote (to amend, refer or reconsider) is not read as a vote on the bill itself. The source does not say which text version each vote was on; every version is linked below.
Official records. Maryland legislators, bills and roll-call votes from the Maryland General Assembly, imported through Open States on Oct 29, 2026. Accuracy review against the official site is still under way. Campaign-finance records for Maryland are not imported yet.